Doç. Dr. Rezzak Yılmaz

Bilimsel Yayınları

HAKEMLİ DERGİLERDE YAYINLANAN MAKALELER

  1. Cakmur R, Donmez Colakoglu B, Yilmaz R, Akbostancı MC. Evidence–based approach to the medical treatment of Parkinson’s disease. Türkiye Klinikleri Journal of Neurology 2008, 4, 51- 57.
  2. Akbostancı MC, Yilmaz R. Botulinum toxin treatment and oromandibular dystonia. Turkish Archives of Neuropsychiatry 2010, 47, supp: 1, 15-18.
  3. Yilmaz R, Arica BS, Yigit A. Lingual myoclonus associated with brain tumor: an epileptic origin? Epileptic Disorders. 2010 Dec; 12(4):303-5.
  4. Yilmaz R, Sarılar AC, Akbostancı MC. Continuous infusion of Apomorphine in a series of thirty patients with Parkinson’s disease. Azerbaijan National Journal of Neurology 2013, 1(3), 55-59.
  5. Akin YA, Yilmaz R, Selcuk F, Akbostancı MC. Sudden onset of oromandibular dystonia after cerebellar stroke. Tremor Other Hyperkinet Mov. 2014 Oct 28; 4:262.
  6. Erdogan S, Yilmaz R, Sorgun MH, Nursel Aydin. Mania as a presenting clinical feature of subacute sclerosing panencephalitis. Acta Neurol Belg, 2015 Dec;115(4):803-5.
  7. Pilotto A, Yilmaz R, Berg D. Developments in the role of transcranial sonography for the differential diagnosis of parkinsonism. Curr Neurol Neurosci Rep. 2015 Jul; 15(7):566.
  8. Soykök G, Yilmaz R, Sentürk A, Cevik S, Gökce SF, Yilmaz ÖK, Topaktas S. Association of sleep quality and daytime sleepiness with cognition in the elderly. Turkish Journal of Geriatrics 2015; 18(2):123-129.
  9. Sorgun MH, Yilmaz R, Mercan FN, Akbostancı MC. Botulinum toxin injections for the treatment of hemifacial spasm over 16 years. J Clin Neurosci. 2015 Aug;22(8):1319-25.
  10. Yilmaz R, Akbostancı MC, Mercan FN, Sorgun MH, Savas A. No effect of different stimulation conditions on verbal fluency and visuospatial orientation in patients with STN DBS. Stereotact Funct Neurosurg. 2015 Sep 10;93(5):326-332.
  11. Yilmaz R, Behnke S, Liepelt-Scarfone I, Roeben B, Pausch C, Runkel A,Heinzel S, Niebler R, Suenkel U, Eschweiler GW, Maetzler W, Berg D. Substantia nigra hyperechogenicity is related to decline in verbal memory in healthy elderly adults. Eur J Neurol. 2016 May; 23(5):973-8.
  12. Yilmaz R, Pilotto A, Roeben B, Preiche O, Suenkel U, Heinzel S, Metzger F.G, Laske C, Maetzler W, Berg D. Structural Ultrasound of the Medial Temporal Lobe in Alzheimer’s Disease. Ultraschall Med.  2017 Jun;38(3):294-300.
  13. Yilmaz R. Transkraniyal Sonografi ile Elektrodun Yerleşim Yerinin Saptanması (Detection of Electrode Localization by Transcranial Sonography) Parkinson Hastalığı ve Hareket Bozuklukları Dergisi (Turkish Journal of Parkinson’s disease and Movement Disorders). 2016;19 (1-2):28-30.
  14. Yilmaz R, Gräber S, Roeben B, Suenkel U, von Thaler AK, Heinzel S, Metzger FG, Eschweiler GW, Maetzler W, Berg D, Liepelt-Scarfone I. Cognitive performance patterns in healthy individuals with substantia nigra hyperechogenicity and early Parkinson’s disease. Front. Aging Neurosci. 2016 Nov 15;8:271.
  15. Aytürk Z, Yilmaz R, Akbostanci MC. Re-emergent tremor in Parkinson’s disease: Clinical and accelerometric properties. J Clin Neurosci. 2017 Mar; 37:31-33.
  16. Yilmaz R, Bayram E, Ulukan C, Altinok MK, Akbostanci MC. Appendectomy History is not Related to Parkinson’s Disease. J Parkinsons Dis. 2017;7(2):347-352.
  17. Pilotto A, Heinzel S, Suenkel U, Lerche S, Brockmann K, Roeben B, Schaeffer E, Wurster I, Yilmaz R, Liepelt-Scarfone I, von Thaler AK, Metzger FG, Eschweiler GW, Postuma RB, Maetzler W, Berg D. Application of the MDS prodromal PD research criteria in two independent prospective cohorts. Mov. Disord. 2017 Jul; 32(7):1025-1034.
  18. Yilmaz R, Berg D. Evaluating a patient with transcranial sonography to look for echogenicity. Mov Disord Clin Pract. (2017), 4: 907.
  19. Yilmaz R, Berg D. Substantia nigra hyperechogenicity for the early detection of Parkinson’s disease. J Neurol Neurophysiol. 2017, 8: 425.
  20. Liepelt-Scarfone I*,Brändle B*,Yilmaz R*,Gauss K, Schaeffer E, Timmers M, Wurster I, Brockmann K, Maetzler W, Van Nueten L, Streffer J, Berg D.Progression of prodromal motor and non-motor symptoms in the Premotor Phase (PMPP) Study – 2 year follow-up data. Eur. J. Neurol. 2017 Nov;24(11):1369-1374 (*ortak ilk yazar)
  21. Drepper C, Geißler J, Pastura G, Yilmaz R, Berg D, Romanos M, Gerlach M. Transcranial sonography in psychiatry as a potential tool in diagnosis and research. World J Biol Psychiatry. 2017 Oct 3:1-29.
  22. Koroglu C*, Yilmaz R*, Sorgun MH, Solakoglu S, Sener O. GNE missense mutation in recessive familial amyotrophic lateral sclerosis. Neurogenetics. 2017 Dec;18(4):237-243 (*ortak ilk yazar)
  23. Heinzel S, Kasten M, Behnke S, Vollstedt EJ, Klein C, Hagenah J, Pausch C, Heilmann R, Brockmann K, Suenkel U, Yilmaz R, Liepelt-Scarfone I, Walter U, Berg D. Age- and sex-related heterogeneity in prodromal Parkinson’s disease. Mov Disord. 2018 Jul;33(6):1025-1027.
  24. Erdogan S, Sorgun MH, Kuzu Z, Yilmaz R, Kuzu M, Ulukan C, Levent HC, Ozer IS, Tezcan S, Rzayev S, Yilmaz V, Isikay CT. Early seizures in patients with acute ischemic stroke patients: incidence, predictive factors and clinical outcome.  Epilepsi. 2018; 24(2): 69-74.
  25. Yilmaz R, Strafella AP, Bernard A, Schulte C, van den Heuvel L, Schneiderhan-Marra N, Knorpp T, Joos TO, Leypoldt F, Geritz J, Hansen C, Heinzel S, Apel A, Gasser T, Lang AE, Berg D, Maetzler W and Marras C. Serum Inflammatory Profile for the Discrimination of Clinical Subtypes in Parkinson’s Disease. Front. Neurol. 2018 Dec 21;9:1123.
  26. Incirli SU, Yilmaz R, Akbostanci MC. Hemifacial spasm in sleep – a polysomnographic study. J Clin Neurosci. 2019 Jun;64:160-162.
  27. Yilmaz R, Bolayir A. Serum osteopontin values in patients with ischemic stroke. Cum. Med. Journal (2019) 41;1 64-88.
  28. Yilmaz R, Hopfner F, van Eimeren T, Berg D. Biomarkers of Parkinson’s disease: 20 years later. J Neural Transm. 2019 Jul;126(7):803-813.
  29. Behnke S, Pilotto A, Liepelt-Scarfone I, Yilmaz R, Pausch C, Dieterich S, Bürmann J, Spiegel J, Dillmann U, Unger M, Posner I, Berg D. Third ventricular width assessed by transcranial ultrasound correlates with cognitive performance in Parkinson’s disease. Parkinsonism Relat Disord. 2019 Sep;66:68-73.
  30. Yilmaz R, Arica-Polat BS. Vitamin D is associated with cognitive status in patients with Alzheimer”s disease. Turkish Journal of Geriatrics. 2019; 22(3): 361-367.
  31. Sahin T, Yilmaz R, Akbostanci MC. Predictive factors for tolerability of tetrabenazine in patients with hyperkinetic movement disorders. Parkinsonism Relat Disord. 2020 May;74:36-37.
  32. Sarilar AC, Ismailogullari S, Yilmaz R, Erdogan FF, Per H.Electroencephalogram abnormalities in patients with NREM parasomnias. Sleep Med. 2021 Jan;77:256-260.
  33. Yilmaz R, Granert O, Schäffer E, Jensen-Kondering U, Schulze S, Bartsch T, Berg D. Transcranial Sonography Findings in Alzheimer’s Disease: A New Imaging Biomarker. Ultraschall Med. 2021 Dec;42(6):623-633.
  34. Sahin T, Karaarslan FT, Yilmaz R, Tekgül Ş, Başak AN, Akbostanci MC. Two cases of early-onset autosomal recessive spastic ataxia of Charlevoix-Saguenay diagnosed in adulthood. Clin Neurol Neurosurg. 2021 Feb;201:106423.
  35. Bayram E, Yilmaz R, Qiu Y, Yalap OE, Aydin O, Ergenc HI, Akbostanci MC. The effect of Subthalamic nucleus deep brain stimulation on verb and noun naming in Turkish-Speaking Parkinson’s disease patients. Brain Lang. 2021 Jan;212:104865.
  36. Aoun K, Double KL, Pearson-Dennett V, Yilmaz R, Berg D, Todd G. Measurement of the adult human midbrain with transcranial ultrasound. PLoS One. 2021 Mar 1;16(3):e0247920.
  37. Elben S, Dimenshteyn K, Trenado C, Folkerts AK, Ophey A, Sulzer P, Becker S, Schmidt N, Tödt I, Witt K, Liepelt-Scarfone I, Yilmaz R, Kalbe E, Wojtecki L. Screen Fast, Screen Faster: A Pilot Study to Screen for Depressive Symptoms Using the Beck Depression Inventory Fast Screen in Parkinson’s Disease With Mild Cognitive Impairment. Front Neurol. 2021 Mar 8;12:640137.
  38. Yilmaz R, Suenkel U; TREND Study Team, Postuma RB, Heinzel S, Berg D. Comparing the Two Prodromal Parkinson’s Disease Research Criteria-Lessons for Future Studies. Mov Disord. 2021 Jul;36(7):1731-1732.
  39. Mychajliw C, Herrmann ML, Suenkel U, Brand K, von Thaler A-K, Wurster I, Yilmaz R, Eschweiler GW and Metzger FG. Impaired Executive Function and Depression as Independent Risk Factors for Reported Delirium Symptoms: An Observational Cohort Study Over 8 Years. Front. Aging Neurosci. 2021 Jun 7;13:676734.
  40. Aykaç Ö, Durmaz Çelik FN, Yilmaz R, Bayram E, Akbostancı MC, Karan O. Akathisia in Parkinson’s Disease: A Comperative Cross-sectional Study. Turk J Neurol. 2022; 28(1): 10-13.
  41. Tugan-Yildiz B, Yilmaz R, Sahin T, Cotur-Levent H, Kar I, Akbostanci MC. What Bothered Patients with Parkinson Disease During The COVID-19 Lockdown? An Analysis of Telephone Records. Turkish Journal of Geriatrics. 2022; 25(1): 173-182.
  42. Say B, Ünal Y, Özaydın Aksun Z, Yilmaz R, Akbostancı MC. The Impact of Prodromal Stage Non-Motor Symptoms on Clinical Progression in Parkinson’s Disease. Journal of Ankara University School of Medicine. 2022;75(1):63-68.
  43. Ünal S, Karaarslan-Turk T, Akbostanci MC, Peker E, Yilmaz R. Botulinum toxin injections in jaw-opening dystonia. The lateral pterygoid – maxillary artery problem. J Clin Neurosci. 2022; 101:217-220.
  44. Ceylan M, Gültekin M, Durmaz Çelik N, Samanci B, Yalçin Çakmakli G, Yilmaz R. Intermittent Subcutaneous Injections of Apomorphine in Parkinson’s Disease. Eurasian J Med. 2022 Dec;54(Suppl1):71-76.
  45. Devos D, Labreuche J, Rascol O, Corvol JC, Duhamel A, Guyon DP, Poewe W, Compta Y, Pavese N, Růžička E, Dušek P, Post B, Bloem BR, Berg D, Maetzler W, Otto M, Habert MO, Lehericy S, Ferreira J, Dodel R, Tranchant C, Eusebio A, Thobois S, Marques AR, Meissner WG, Ory-Magne F, Walter U, de Bie RMA, Gago M, Vilas D, Kulisevsky J, Januario C, Coelho MVS, Behnke S, Worth P, Seppi K, Ouk T, Potey C, Leclercq C, Viard R, Kuchcinski G, Lopes R, Pruvo JP, Pigny P, Garçon G, Simonin O, Carpentier J, Rolland AS, Nyholm D, Scherfler C, Mangin JF, Chupin M, Bordet R, Dexter DT, Fradette C, Spino M, Tricta F, Ayton S, Bush AI, Devedjian JC, Duce JA, Cabantchik I, Defebvre L, Deplanque D, Moreau C, FAIRPARK-II Study Group (listed in the group as collaborator). Trial of Deferiprone in Parkinson’s Disease. N Engl J Med. 2022 Dec 1;387(22):2045-2055.
  46. Kayis G, Yilmaz R, Arda B, Akbostancı MC. Risk disclosure in prodromal Parkinson’s disease – A survey of neurologists. Parkinsonism Relat Disord. 2023 Jan;106:105240.
  47. Eldemir S, Guclu-Gunduz A, Eldemir K, Saygili F, Yilmaz R, Akbostancı MC. The effect of task-oriented circuit training-based telerehabilitation on upper extremity motor functions in patients with Parkinson’s disease: A randomized controlled trial. Parkinsonism Relat Disord. 2023 Apr;109:105334.
  48. Yekedüz MK, Yilmaz R, Kayis G, Doğulu N, Öncül Ü, Abali T, Temizyurek AD, Çelik G, Çöklü H, Gemci E, Yalcin A, Ceylaner S, Akbostancı MC, Eminoğlu FT. Genetic variants of GBA and GLA in a Turkish cohort of Parkinson’s disease: A preliminary report. Parkinsonism Relat Disord. 2023 May;110:105390.
  49. Karacan AV, Kibrit S, Yekedüz MK, Doğulu N, Kayis G, Unutmaz EY, Abali T, Eminoğlu FT, Akbostancı MC, Yilmaz R. Cross-cultural Differences in Stigma Associated with Parkinson’s Disease: A Systematic Review. J Parkinsons Dis. 2023;13(5):699-715.
  50. Yilmaz R, Wolke R, Puls N, Sorgun MH, Deuschl G, Berg D, Margraf N. Characterizing Camptocormia in Parkinson’s Disease Using Muscle Ultrasonography. J Parkinsons Dis. 2023;13(5):819-827.
  51. Yilmaz R, Dilek GR, Kayis G, Abali T, Yalçın-Çakmaklı G, Arda B, Elibol B, Akbostancı MC. Disclosing the news of future risk of Parkinson’s disease: What do patients think? Parkinsonism Relat Disord. 2023 Nov;116:105895.
  52. S. Philippen, A. Hanert, R. Schönfeld, O. Granert, R. Yilmaz, U. Jensen-Kondering, M. Splittgerber, V. Moliadze, M. Siniatchkin, D. Berg, T. Bartsch. Transcranial direct current stimulation of the right temporoparietal junction facilitates hippocampal spatial learning in Alzheimer’s disease and mild cognitive impairment. Clinical Neurophysiology, 2023 Nov 15:157:48-60.
  53. Eldemir S, Eldemir K, Saygili F, Ozkul C, Yilmaz R, Akbostancı MC, Guclu-Gunduz A. The effects of standard and modified LSVT BIG therapy protocols on balance and gait in Parkinson’s disease: A randomized controlled trial. Brain Behav. 2024 Mar;14(3):e3458.

KİTAP BÖLÜM YAZARLIĞI

  1. Yilmaz R, Akbostancı MC, Savas A. Surgical treatment of Parkinson’s disease (Parkinson Hastalığı’nın cerrahi tedavisi). Parkinson Hastalığı. Emre M. Güneş Publishing 2009, 345-357.
  2. Yilmaz R, Akbostancı MC. Ileri evre Parkinson Hastalığı’nın tedavisinde medikal ve cerrahi yaklaşımlar (Medical and surgical approaches to the treatment of advanced stage Parkinson’s disease). Hareket Bozuklukları (Movement Disorders). Elibol B.  Rotatıp Publishing 2011, 163-177.
  3. Yilmaz R. Hareket Bozukluklarında Transkraniyal Sonografi (Transcranial Sonography in Movement Disorders). Klinik Pratikte Hareket Bozuklukları (Movement disorders in Clinical Practice) Akbostanci MC. Ada Publishing 2018, second edition.
  4. Yilmaz R, Berg D. Transcranial B-Mode Sonography in Movement Disorders. Imaging Applications in Non-Parkinsonian and Other Movement Disorders. Politis M. Elsevier Publishing 2018;143:179-212.

POSTER VE SÖZEL BİLDİRİLER

  1. Yücesan C, Erden I, Sarıkaya AC, Yilmaz R, Sorgun M. A case; Wallerian degeneration. Kasım, 2008 44. Ulusal Nöroloji Kongresi, Antalya.
  2. Sarıkaya AC, Sorgun MH, Yilmaz R, Yiğit A.  A case; Acute cerebellitis in Crohn disease. Kasım, 2008 44. Ulusal Nöroloji Kongresi, Antalya.
  3. Akbostanci CM,  Durmaz NF, Arica BS, Yilmaz R. Cervical injury-related polymininnyoclonus: Case report. 14th International Congress of Parkinson’s Disease and Movement Disorders, Buenos Aires, Argentina, 2010. Mov Disord 2010: 25;7 Suppl s, 489-S489.
  4. Arica BS, Yilmaz R, Akbostanci MC. Abdominal myoclonus associated with vitamin B12 deficiency: Report of three cases. 14th International Congress of Parkinson’s Disease and Movement Disorders, Buenos Aires, Argentina, 2010. Mov Disord 2010; 25, 7 Supp S 490-S490.
  5. Akbostancı MC, Yılmaz R, Sarılar Ç. Apomorfin infüzyonu Ankara Tıp deneyimi. 47. Ulusal Nöroloji Kongresi, Antalya. Bildiri Metinleri Kitabı, 2011, s90.
  6. Yilmaz R, Isıkay C, Cila A. Atypical multiple cerebral calcifications: A case report. Kasım, 2011 47. Ulusal Nöroloji Kongresi, Türkiye.
  7. Heinzel S, Yilmaz R, Liepelt-Scarfone I, Roeben B, Niebler R, Eschweiler G, Fallgatter A, Metzger F, Maetzler W, Berg D. Substantia nigra hyperechogenicity and cognitive functions: Results from the TREND study (865): 19th International Congress of Parkinson’s Disease and Movement Disorders, San Diego, USA. Mov Disord. 2015; 30.
  8. Heinzel S, Suenkel U, Metzger F.G, Schaeffer E, Roeben B, Yilmaz R, Lerche S, Brockmann K, von Thaler A.K, Liepelt-Scarfone I, Eschweiler G.W, Fallgatter A.J, Maetzler W, Berg D. Effects of gender, age and hyposmia on cognitive functions in healthy elderly individuals at risk for Parkinson’s disease: Results from the TREND study [abstract]. Mov Disord. 2016; 31 (suppl 2).
  9. Behnke S, Pilotto A, Liepelt-Scarfone I, Yilmaz R, Pausch C, Dieterich S, Posner I, Spiegel J, Dillmann U, Unger M, Schmidl B, Bürmann J, Fassbender K, Berg D. Transcranial sonography and cognitive dysfunction in Parkinson’s disease [abstract]. Mov Disord. 2016; 31 (suppl 2).
  10. Behnke S, Pilotto A, Liepelt-Scarfone I, Yilmaz R, Pausch C, Dieterich S, Posner I, Spiegel J, Dillmann U, Unger M, Schmidl B, Bürmann J, Fassbender K, Berg D. Transcranial sonography and cognitive dysfunction in Parkinson’s disease. 10. Deutscher Parkinson-Kongress und 6. Deutscher Botulinumtoxin-Kongress 2017 Baden-Baden, Germany, 2017.
  11. Pilotto A, Heinzel S, Suenkel U, Lerche S, Brockmann K, Roeben B, Schaeffer E, Wurster I, Yilmaz R., Liepelt-Scarfone I, von Thaler AK, Metzger F, Eschweiler G, Postuma R, Maetzler W, Berg D. MDS prodromal PD research criteria validation in two independent prospective cohorts [abstract]. Mov Disord. 2017; 32 (suppl 2).
  12. Sarılar C, Yılmaz R. L4-5 kisa segment yapilan vida plak yapilan hastalarda L4 pelvik insidans değerlerinde değişiklikler. 33. Türk Nöroşirürji Derneği Bilimsel Kongresi. 2019. PS-406.
  13. Bayram E, Yilmaz R, Longardner K, Akbostanci M, Litvan I. Daytime Sleepiness Effects on Motor Symptoms in De Novo Parkinson’s Disease [abstract]. Mov Disord. 2019; 34 (suppl 2).
  14. Durmaz-Çelik N, Yılmaz R, Akbostancı MC.Parkinson Hastalığında Psikozun Ortaya Çıkışına Demansın Etkisi, 10. Ulusal Alzheimer Sanal Kongresi, 2020 s.22.
  15. Sahin T, Yilmaz R, Akbostanci MC. Saccadic and Smooth Pursuit Derangements in Essential Tremor: A Video Oculography Study [abstract]. Mov Disord. 2020; 35 (suppl 1).
  16. Kayis G, Yilmaz R, Yalcin-Cakmakli G, Arda B, Elibol B, Akbostanci, MC. Attitudes towards risk disclosure in prodromal Parkinson’s disease. Is there a cultural difference? [abstract]. Mov Disord. 2021; 36 (suppl 1).
  17. Unal S, Karaarslan-Turk T, Akbostanci C, Peker E, Yilmaz R. Approaching the lateral pterygoid muscle in botulinum toxin injections: How to avoid the maxillary artery. [abstract]. Mov Disord. 2021; 36 (suppl 1)
  18. Yekedüz MK, Yılmaz R, Doğulu N, Öncül Ü, Ceylaner S, Akbostancı C, Eminoğlu FT. Role of GLA variants in Parkinson’s Disease. JIMD 2021, 44:1, p.97.
  19. Yekedüz MK, Yılmaz R, Öncül Ü, Doğulu N, Ceylaner S, Akbostancı C, Eminoğlu FT. Newly detected GBA variants in Turkish patients with Parkinson’s disease. JIMD 2021, 44:1, p.427.
  20. Yekedüz MK, Yılmaz R, Öncül Ü, Doğulu N, Çelik G, Ceylaner S. Whole Exome Sequencing in GBA-related Parkinson’s Disease. JIMD 2021, 44:1, p.554.
  21. Eldemir S, Eldemir K, Saygılı F, Güçlü-Gündüz A, Yılmaz R, Akbostancı MC. Telerehabilitation Based Task Oriented Training in Improving Upper Extremity Motor Function in Parkinson’s Patients: A Pilot Study. Nov 2021. Union of Thrace Universities IV. International Health Sciences Congress, Book of Abstracts, p 173.
  22. Yekedüz MK, Yılmaz R, Doğulu N, Öncül Ü, Ceylaner S, Ceylaner G, Ylaçın A, Akbostancı C, Eminoğlu FT. Parkinson Hastalarında GBA ve GLA Varyantlarının Araştırılması ve Tüm Ekzom Dizi Analizi (53) VII. Uluslararası Katılımlı Lizozomal Hastalıklar Kongresi (Çevrimiçi). 25-27 Kasım 2021.
  23. Kibrit SN, Karacan AV, Kayis G, Yilmaz R, Akbostanci MC. Studies on stigma in Parkinson’s disease in the world. A literature review. A literature review [abstract]. Mov Disord. 2022; 37 (suppl 1).
  24. Abali T, Kayiş G, Unutmaz EY, Temizyürek AD, Koç-Yekedüz M, Öncül Ü, Eminoğlu T, Şahin T, Yilmaz R, Akbostanci MC, Yakişikli I. Parkinson Hastalarında Abur Cubur Tüketimi Ve İlişkili Faktörler. Hareket Hastalıklarında Tanı ve Tedavide Güncel ve Gelecek Yaklaşımlar. 26-29 Mayıs, Nevşehir. S11-12.
  25. Yilmaz R, Abali T, Unutmaz EY, Kayiş G, Koç-Yekedüz M, Dogulu N, Şahin T, Ayik G, Genç-Batmaz D, Kibrit SN, Karacan AV, Yakişikli I, Eminoğlu T, Akbostanci MC. Türk Parkinson Hastalarında Komorbiditeler, Risk Faktörleri Ve Yaşam Tarzı: Tanımlayici Bir Çalışma. Hareket Hastalıklarında Tanı ve Tedavide Güncel ve Gelecek Yaklaşımlar, 2022, 26-29 Mayıs, Nevşehir. S15-17.
  26. Özaltun B, Bulut O, Yılmaz R, Akbostancı MC. C19ORF12 geninde homozigot varyant MPAN vakası. 59. Ulusal Nöroloji Kongresi, EP-312.
  27. Özaltun B, Öztürk G, Kara R, Ayık G, Genç-Batmaz D, Özkaya G, Muya M, Çoban B, Özdemir B, Akbostancı MC, Büyükatalay ZÇ, Tokgöz-Yılmaz S, Yılmaz R , Şener HÖ. SPeech In Neurological Diseases – TuRkish (SPIND-TR) çalışması: Çalışma protokolü ve ilk sonuçlar. 59. Ulusal Nöroloji Kongresi, SS-65.
  28. Çağlayan MG, Yilmaz R, Evren E, Karaçor B, Yıldız D, Arslan BC, Şeker UÖŞ, Akbostancı MC. Parkinson hastalığı tanısında Real-Time Quaking-Induced Conversion (RT-QUIC) testi ve farklı α-sinüklein proteinlerinin rolü. 59th Ulusal Nöroloji Kongresi, SS-67.
  29. Abali T, Yekedüz MK, Yilmaz R, Kayis G, Unutmaz EY, Karacan AV, Kibrit SN, Ceylaner S, Akbostancı MC, Eminoğlu FT. The effect of GBA variants on Turkish patients with Parkinson’s disease. Meeting of The American Society of Human Genetics, November 1-5, 2023 in Washington DC, USA.
  30. Abali T, Karacan AV, S Kibrit SN, Yekedüz MK, Unutmaz EY Eminoğlu FT, Yilmaz R, Akbostancı MC. The effect of peptic ulcer disease on Parkinson’s disease. Mov Disord. 2023; 38.
  31. Yilmaz R, Wolke R, Puls N, Sorgun M, Deuschl G, Berg D, Margraf N. Detection of Camptocormia Using Ultrasound in Parkinson’s Disease. Mov Disord. 2023; 38.
  32. Yilmaz R, Öksüz N, Samancı B, Acarer A, Ceylan M, Durmaz-Celik N, Erdem H, Özkan S, Hanağası H, Doğu O, Akbostancı MC. Diagnostic and treatment burden of dystonia in Turkey: a patient journey map. Mov Disord. 2023; 38